HOME >> MEDICINE >> NEWS
Pioglitazone shown to reverse thickening of carotid artery wall

Mainz, Germany, November 9, 2004 Clinical study results presented today in New Orleans, Louisiana, during the American Heart Association's Scientific Sessions 2004 proceedings, have shown that the drug pioglitazone (ACTOS, Takeda) significantly reduced the thickness of the carotid (neck) artery in patients with type 2 diabetes. By contrast, no change in carotid thickness was seen in a group of patients who received glimepiride, an older drug for type 2 diabetes.

"These results are provocative, because both drugs showed similar effects on lowering blood glucose, the traditional principal target for type 2 diabetes therapy," noted principal investigator Thomas Forst, Professor for Internal Medicine, Institute for Clinical Research and Development in Mainz, Germany.

"The thickness of the carotid artery is an indicator of atherosclerotic disease, which may both reduce arterial blood flow and set the stage for unstable blood clots in the arteries to dislodge and potentially cause a heart attack or stroke. The reduction in thickness by pioglitazone, a member of a new class of type 2 diabetes drugs called thiazolidinediones (TZDs) suggests that this medication may have benefits beyond improving metabolic control in patients with diabetes mellitus type 2," continued Forst. "This substantial regression of carotid intima media thickness over just 12 or 24 weeks may have important prognostic implications for patients with type 2 diabetes."

Study Design and Results

In the study, B-mode ultrasound was used to measure the intima media thickness (IMT) of the carotid artery before and 12 and 24 weeks after 173 patients received oral therapy with either pioglitazone (45 mg/day) or glimepiride (1-6 mg/day). Baseline carotid IMT was 0.949 0.149mm in the pioglitazone group and 0.924 0.150mm in the glimepiride group (p=n.s.). Carotid IMT was reduced only in the pioglitazone group after 12 weeks (-0.033 0.052mm) vs. -0.002 0.047mm
'"/>

Contact: Kate Sullivan
646-284-6514
Ketchum
9-Nov-2004


Page: 1 2

Related medicine news :

1. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
2. Cartilage repair techniques shown to restore patient mobility and reduce pain
3. Sprinklers shown effective in slowing dorm fires
4. Controversial drug shown to act on brain protein to cut alcohol use
5. HPV vaccine shown effective at reducing cancer-causing infections
6. HPV vaccine shown to substantially reduce cervical cancer
7. New research results: Heart jacket shown to be effective
8. Isolated soy protein shown to benefit type 2 diabetics, study indicates
9. Increased risk of cardiovascular disease shown in PCOS patients
10. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
11. Anti-eosinophil therapy shown to be effective in treating hypereosinophilic syndrome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... YORK (PRWEB) , ... May 05, 2016 , ... TIME ... swimming safety – today announced a new partnership to reach nearly 1 million children ... happen in an instant and is the leading cause of accidental death in children ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... Jennifer Drago presented a talk highlighting the organization’s successful Care Transitions ... Chicago. , The talk was titled “Minimizing Costs in the Post-Acute Environment Through ...
(Date:5/5/2016)... ... May 05, 2016 , ... The 2016 Nike Soccer Camp will ... with his university coaching staff. Together they bring their winning Vandals coaching philosophy to ... youth players ages 5-13, and high school players. Session dates are as follows: , ...
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs (TTL) ... the eve of National Nurses Week (May 6-12). Currently, HireNurses is a ... their enrollment into the Talent Tech Lab Virtual Incubation program, they will dramatically expand ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Collection Bureau, Inc. ... Clark brings more than 15 years of experience within the healthcare revenue cycle industry. ... career as the Director of Patient Financial Services at Spectrum Health. While at Spectrum ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 5, 2016 Research and Markets has ... Imaging in the USA"  report to their offering.  ,     ... on the current Positron Emission Tomography (PET) scanner and ... market. Along with the current known number of ... , the report also contains a detailed breakdown ...
(Date:5/5/2016)... DUBLIN , May 5, 2016 /PRNewswire/ ... the addition of the  "Europe Systemic Lupus ... 2016"  report to their offering.  ... The latest research Europe Systemic Lupus ... 2016, provides comprehensive insights into Systemic Lupus ...
(Date:5/4/2016)... NEW YORK , May 4, 2016 ... Size, Share, Development, Growth and Demand Forecast to 2022 - ... End User (Hospital, Diagnostic Center and Others)" by P&S Market ... at $4,894.3 million in 2015, and it is expected to ... slice type, the high slice type segment is expected to ...
Breaking Medicine Technology:
Cached News: